Amylyx Pharmaceuticals Inc’s recent filing unveils that its Chief Legal Officer Mazzariello Gina unloaded Company’s shares for reported $12839.0 on Feb 03 ’25. In the deal valued at $3.49 per share,3,678 shares were sold. As a result of this transaction, Mazzariello Gina now holds 139,090 shares worth roughly $0.42 million.
Then, Cohen Joshua B sold 11,851 shares, generating $41,108 in total proceeds. Upon selling the shares at $3.47, the Co-Chief Executive Officer now owns 3,201,247 shares.
Before that, Klee Justin B. sold 11,855 shares. Amylyx Pharmaceuticals Inc shares valued at $41,104 were divested by the Co-Chief Executive Officer at a price of $3.47 per share. As a result of the transaction, Klee Justin B. now holds 3,164,933 shares, worth roughly $9.49 million.
Robert W. Baird upgraded its Amylyx Pharmaceuticals Inc [AMLX] rating to an Outperform from a a Neutral in a research note published on November 18, 2024; the price target was increased to $11 from $3. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in late October from “a Neutral” to “a Buy”. Mizuho also remained covering AMLX and has decreased its forecast on March 18, 2024 with a “Neutral” recommendation from previously “Buy” rating. Robert W. Baird revised its rating on March 11, 2024. It rated AMLX as “a Neutral” which previously was an “an Outperform”.
Price Performance Review of AMLX
On Friday, Amylyx Pharmaceuticals Inc [NASDAQ:AMLX] saw its stock fall -9.09% to $3.00. Over the last five days, the stock has lost -19.35%. Amylyx Pharmaceuticals Inc shares have fallen nearly -20.63% since the year began. Nevertheless, the stocks have fallen -80.40% over the past one year. While a 52-week high of $19.95 was reached on 01/03/25, a 52-week low of $1.58 was recorded on 02/24/25. SMA at 50 days reached $3.72, while 200 days put it at $3.18.
Levels Of Support And Resistance For AMLX Stock
The 24-hour chart illustrates a support level at 2.86, which if violated will result in even more drops to 2.72. On the upside, there is a resistance level at 3.27. A further resistance level may holdings at 3.54. The Relative Strength Index (RSI) on the 14-day chart is 33.06, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.28, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.97%. Stochastics %K at 12.44% indicates the stock is a buying.
